| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 536170200 |
Nitrogen containing
| 93 |
| 536180100 |
Polycyclo ring system (e.g., hellebrin, etc.)
| 77 |
| 536700100 |
Oxygen containing hetero ring having 12-19 members (e.g., methymycin, carbomycin, spiramycin, etc.)
| 34 |
| 536180500 |
Processes
| 31 |
| 536005000 |
Cyclopentanohydrophenanthrene ring system
| 30 |
| 536170100 |
Boron, phosphorus, heavy metal or aluminum containing
| 27 |
| 536180200 |
Containing -C(=X)X- wherein the X's are the same or diverse chalcogens
| 24 |
| 536600400 |
Daunomycin or derivative
| 15 |
| 536180400 |
Halogen containing
| 9 |
| 536160800 |
Antibiotics
| 8 |
| 536600500 |
Oxygen containing hetero ring having at least twenty members (e.g., amphotericin, nystatin, pimaricin, etc.)
| 6 |
| 536008000 |
Flavon sugar compounds | 5 |
| 20090054635 | CORN INBREDS LIKE FAR601 AND HYBRIDS THEREOF - A maize inbred line having the characteristics selected from those of FAR601, including plant parts, tissue, and pigments of the inbred is disclosed. | 02-26-2009 |
| 20090111975 | METHOD FOR THE SYNTHESIS OF ANTHOCYANINS - The present invention relates to methods of preparing anthocyanins, and methods of preparing precursors of anthocyanins. The methods utilise a coupling reaction between a sugar and a suitable electrophilic precursor to form Eastern half intermediates that are then reacted with Western half intermediates to form the target anthocyanins. Some Eastern half intermediates and electrophilic precursors also form part of the invention. | 04-30-2009 |
| 20100029918 | NOVEL POLYPHENOL GLYCOSIDE ISOLATED FROM ACEROLA - It is an objective of the present invention to provide a polyphenol glycoside isolated from acerola, which has a binding mode that has not been conventionally known, and to provide the use of the same. | 02-04-2010 |
| 20100093984 | EXTRACTION METHOD - The present invention relates to a process for the preparation of tiliroside or tiliroside-containing extracts from parts of a plant selected from the Sterculiaceae family, to corresponding extracts, and to the use of the extracts or process products in cosmetics or topical applications. | 04-15-2010 |
| 20130085270 | MANUFACTURING METHOD FOR POLYPHENOL COMPOSITION - A method for producing a polyphenol composition including a step of subjecting (A) a hardly water-soluble polyphenol and (B) one or more selected from cathechins, chlorogenic acids and methylated compounds of hardly water-soluble polyphenols to a heat treatment at from 100 to 180° C. in the presence of an aqueous medium. | 04-04-2013 |
| 536130700 |
Kanamycin or derivative | 4 |
| 20110245476 | ANTIBACTERIAL 4,6-SUBSTITUTED 6', 6" AND 1 MODIFIED AMINOGLYCOSIDE ANALOGS - The present invention is directed to analogs of aminoglycoside compounds as well as their preparation and use as prophylactic or therapeutics against microbial infection. | 10-06-2011 |
| 20130005953 | Readthrough Inducing Agent and Drug for Treating Genetic Disease Caused by Nonsense Mutation - A readthrough inducing agent for inducing readthrough of a premature stop codon generated by nonsense mutations, the readthrough inducing agent comprising a compound having a structure expressed by the following Structural Formula (A), and a drug for treating a genetic disease caused by nonsense mutations, the drug comprising the readthrough inducing agent. | 01-03-2013 |
| 20130144044 | ANTIBACTERIAL 4,6-SUBSTITUTED 6', 6'' AND 1 MODIFIED AMINOGLYCOSIDE ANALOGS - The present invention is directed to analogs of aminoglycoside compounds as well as their preparation and use as prophylactic or therapeutics against microbial infection. | 06-06-2013 |
| 20080214798 | Sugar chain asparagine derivatives, sugar chain asparagine, sugar chain and processes for producing these - An asparagine-linked α2,3-oligosaccharide having undeca- to hepta-saccharides, an asparagine-linked α2,6-oligosaccharide having undeca- to hepta-saccharides and containing fluorine and an asparagine-linked oligosaccharide derivative containing at least one fucose in N-acetylglucosamine on the nonreducing terminal side of an asparagine-linked oligosaccharide wherein the asparagine has amino group protected with a lipophilic protective group, and a process for producing these compounds. | 09-04-2008 |
| 536013000 |
Novobiocin or derivative | 3 |
| 20090187014 | Novobiocin Analogues - Novobiocin analogues and pharmaceutical composition containing such compounds useful for the treatment and/or prevention of neurodegenerative disorders and autoimmune disorders, as well as cancer. | 07-23-2009 |
| 20100048882 | Novobiocin Analogues as Anticancer Agents - Novel analogues and derivatives of novobiocin are provided, including compounds having modifications to the amide side chain, coumarin ring, and sugar moieties. The compounds of the present invention are useful as heat shock protein 90 inhibitors, and may be used as anticancer and neuroprotective agents. | 02-25-2010 |
| 20120264924 | Glycorandomization and Production of Novel Novobiocin Analogs - The present invention provides glycorandomized structures and combinatorial methods for rapidly generating a diverse library of glycorandomized structures, comprising incubating one or more aglycons and a pool of NDP-sugars in the presence of a glycosyltransferase. The glycosyltransferase may be one that is associated with or involved in production of natural secondary metabolites, or one which is putatively associated with or involved in production of natural secondary metabolites. The glycosyltransferase may show significant flexibility with respect to its NDP-sugar donors and/or its aglycons. NDP-sugar donors may be commercially available, or may be produced by utilizing mutant or wild type nucleotidyltransferases significant flexibility with respect to their substrates. | 10-18-2012 |
| 536180300 |
Plural oxyalkylene groups bonded directly to each other | 2 |
| 20100190969 | NON-NATURALLY OCCURRING CARBOHYDRATE-BASED FIBROUS ELEMENTS AND METHODS FOR MAKING SAME - Non-naturally occurring carbohydrate-based fibrous elements and more particularly, non-naturally occurring carbohydrate-based fibrous elements having a macrostructure and a microstructure wherein the microstructure is visible when wet and methods for making same are provided. | 07-29-2010 |
| 20120095198 | METHOD FOR SEPARATING NEUTRAL AND POLAR LIPIDS AND AN OIL RICH IN POLAR LIPIDS - A method for separating neutral and polar lipids from an oil of biological material, wherein the oil is fractionated using a mixture of a polar solvent comprising at least one carbon atom, water and an additional substance selected from the group consisting of: mono-, di- and oligosaccharides comprising from 3 to 10 monosaccharide units, said additional substance is present in an amount of at least 0.1 wt % calculated on the total weight of solvent, water and additional substance, to form at least two liquid fractions having different densities, wherein one fraction is rich in polar lipids and another fraction is rich in neutral lipids. An oil rich in polar lipids obtained from the method is disclosed, said oil I contains at least 40, preferably at least 50 lipid % polar lipids as calculated on the total amount of lipids in said oil and that the total amount of polar solvent and water in said oil is between 20 and 30 wt %. An oat oil containing high amounts of estolides of DGDG can further be obtained. | 04-19-2012 |
| 536130600 |
Gentamicin or derivative | 1 |
| 20110294994 | Gentamicin Separation Method - The invention provides more effective methods of separating the components of gentamicin using a UV active protecting group suitable for use with HPLC. | 12-01-2011 |
| 536130200 |
Neomycin B or neomycin C or derivative | 1 |
| 20140330001 | METHODS AND COMPOSITIONS RELATED TO NUCLEIC ACID BINDING ASSAYS - Small molecule fluorescent probes for established drug targets such as nucleic acids including DNA and RNA has been developed and disclosed herein. These nucleic acid probes bind to multiple DNA and RNA structures, and to sites crucial for nucleic acid function, such as DNA and RNA major grooves. Displacement of the probes by other binders such as small molecule compounds and/or proteins illicits a fluorescence change in the probe that once detected and analyzed provide binding information of these other binders of interest. Similarly, changes in fluorescence upon binding of the probes to nucleic acid have been applied to screen nucleic acid of different sequence and conformation. The nucleic acid probes and method of uses disclosed herein are advantageously suitable for high-through put screening of libraries of small molecule compounds, proteins, and nucleic acids. | 11-06-2014 |
| Entries |
| Document | Title | Date |
|---|
| 20080242849 | Wrinkle-Diminishing Agent - An antiwrinkle agent which is highly effective in alleviating wrinkles caused by the photoaging. The present invention relates to an antiwrinkle agent comprising an eugenyl glycoside. | 10-02-2008 |
| 20080287662 | Balanites Aegyptiaca Saponins and Uses Thereof - The invention relates to stable preparations of saponin nanovesicles, which can encapsulate active biological or chemical materials such as drugs, pesticides, vitamins, minerals and nutrients, and protect them. The preparations can be used, for example, in agricultural, pesticidal, dermatological and cosmetic compositions. The saponins per se can further be used as adjuvants for irrigation water. The invention further relates to novel saponins extracted from | 11-20-2008 |
| 20090069551 | Flavorant Compounds - A compound of the Formula (I) wherein A is selected from the group consisting of —CH═CH—CO—CH3 and —CH2CH2—CO—CH3. The compounds are useful as flavorants in compositions such as foodstuffs, beverages, confectionery, medicinal preparations, dentifrices and mouthwashes. | 03-12-2009 |
| 20090163700 | GRANULATED MALTITOL FOR DIRECT COMPRESSION AND METHOD OF PREPARATION THEREOF - The invention relates to a granulated maltitol of concentration greater than or equal to 97%, preferably between 98 and 99%, characterized in that it has a water content less than 1%, preferably less than 0.5%, more preferably less than or equal to 0.4%, a compressibility greater than or equal to 300 N, preferably between 300 and 500 N, and a hygroscopicity less than or equal to 2.5%, preferably between 0.15 and 2.5%. | 06-25-2009 |
| 20090182132 | RECTANGULAR PARALLELEPIPEDAL MALTITOL - The invention concerns maltitol crystals, characterized in that they have a rectangular parallelepipedal shape and have a length to width dimensional ratio in the range 1.8 to 5.3, preferably 3±0.7, and a process for producing them. | 07-16-2009 |
| 20090187013 | SYNTHETIC HEPARIN PENTASACCHARIDES - Preparation of synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids. | 07-23-2009 |
| 20090221806 | Method for Producing a Beta-1,3-Glucan With Improved Characteristics - In this process for preparing a β-1,3-glucan, the glucan-containing matrix is treated with a protein having β(1,3)-glucanase activity, wherein the concentration of the glucanase amounts from 0.001 to 3.0% by weight. The glucan-containing matrix can be a fermentation broth, a culture medium or a suspension, where appropriate containing unsolved solids, cell constituents and/or cell fragments, or else a mycelium, a hydrocolloid or a powder preparation having a solvent proportion of from 20 to 99.9% by weight. The duration of the enzymatic treatment should be between 15 minutes and 24 hours and the treatment should be carried out continuously. The invention also envisages the glucan-containing matrix being filtered or centrifuged, after it has been treated enzymatically, and the glucan finally being separated off. A β-1,3-glucan which has been prepared in this way and which exhibits, for example, improved solubility in cold water, reduced proportions of insoluble constituents, an increased viscosity or improved filterability, is also claimed. A solid formulation and the use of these glucans for cosmetic applications, foodstuffs or oil production are also coclaimed. | 09-03-2009 |
| 20100168405 | ACTIVATOR INCLUDING BIOSURFACTANT AS ACTIVE INGREDIENT, MANNOSYL ERYTHRITOL LIPID, AND PRODUCTION METHOD THEREOF - The present invention includes as an active ingredient at least one biosurfactant, in particular mannosyl alditol lipid (such as MEL and MML) or triacylated mannosyl alditol lipid. This allows providing an activator and anti-aging agent that is excellent in activating and anti-aging effects on cells and that is safe enough to be used for a long time, and also providing cosmetics, quasi-drugs, drugs, and drinks and foods including the activator and the anti-aging agent as active ingredients. Further, the present invention provides MEL whose mannosyl erythritol skeleton in a molecular structure is 1-O-β-D-mannopyranosyl-meso-erythritol and a method for producing the MEL with use of a microorganism. | 07-01-2010 |
| 20100228013 | ACTIVATOR INCLUDING BIOSURFACTANT AS ACTIVE INGREDIENT, MANNOSYL ERYTHRITOL LIPID, AND PRODUCTION METHOD THEREOF - The present invention includes as an active ingredient at least one biosurfactant, in particular mannosyl alditol lipid (such as MEL and MML) or triacylated mannosyl alditol lipid. This allows providing an activator and anti-aging agent that is excellent in activating and anti-aging effects on cells and that is safe enough to be used for a long time, and also providing cosmetics, quasi-drugs, drugs, and drinks and foods including the activator and the anti-aging agent as active ingredients. Further, the present invention provides MEL whose mannosyl erythritol skeleton in a molecular structure is 1-O-β-D-mannopyranosyl-meso-erythritol and a method for producing the MEL with use of a microorganism. | 09-09-2010 |
| 20110105738 | DIARYL HEPATONOID-BASED COMPOUNDS USEFUL AS VIRUS INHIBITORS - The present invention relates to the use of diaryl hepatonoid-based compounds of formula (1) for inhibiting viral activity. The diaryl hepatonoid-based compounds have an excellent effect of inhibiting viral activity, and thus will be useful as therapeutic agents against virus-related diseases. | 05-05-2011 |
| 20110144316 | METHOD FOR RESTRUCTURING THE EPIDERMIS USING A POLYOL-GLYCOSIDE COMPOSITION - A method for restructuring the epidermis with a composition, wherein said composition includes a polyol-glycoside and said polyol-glycoside is obtained by the acetalization of a polyol with a reducing sugar. | 06-16-2011 |
| 20120149886 | PRODUCTION OF CAROTENOIDS IN OLEAGINOUS YEAST AND FUNGI - The present disclosure provides systems for producing engineered oleaginous yeast or fungi that express carotenoids. | 06-14-2012 |
| 20120264923 | LOW-VISCOSITY LIQUID CRYSTAL COMPOUND - The present invention relates to a liquid crystal compound that can be used as a base for injection formulations. The present invention provides an amphipathic compound having the following general formula (I): | 10-18-2012 |
| 20130041142 | HUMAN SWEET TASTE RECEPTOR-ACTING SWEET TASTE REGULATING SUBSTANCE TO SWEET TASTE SUBSTANCE - [Object] An object of the present invention is to provide a human sweet taste receptor-acting sweet taste regulating substance to a sweet taste substance by which the advantageous effects such as improvement in a taste, saving of a sweetener, reduction in calorie, low caries etc. can be obtained by applying to various foods and beverages. | 02-14-2013 |
| 20130150567 | GLYCOLIPIDS OF BRANCHED CHAIN ALKYL OLIGOSACCHARIDES FOR LIQUID CRYSTAL AND RELATED APPLICATIONS - Glycolipids of branched chain alkyl oligosaccharides according to this patent comprise of a primary alcohol branched in the 2-position and an oligosaccharide, covalently bond to the alcohol in either α- or β-linkage (shown in Formula I and Formula II). These compounds show particularly interesting phase behavior not found for the corresponding straight chain counterparts. The properties involve an ambient temperature liquid crystalline appearance and thermotropic liquid crystal phase polymorphism. Upon the latter, the formation of cubic phases is considered most interesting with respect to life science applications, e.g. liposome for drug delivery. Depending on the choice of sugar head group and alkyl tail, various levels of water miscibility may be adjusted to meet applications requirements (complete solubility for emulsifier applications, e.g. cosmetic creams, to limited water swelling only, e.g. for the preparation of artificial membranes). The closed structural relationship to natural lipids also make branched chain alkyl oligosaccharides valuable subjects for biochemical investigations, e.g. membrane studies. The range of possible applications for glycolipids of branched chain alkyl oligosaccharides involve material science liquid crystal applications, e.g. optical switches, as well as surfactants and the life science applications (see above). | 06-13-2013 |
| 20140296497 | Method for Producing Myo-Inositol and Myo-Inositol Derivative - [Problem] To impart significantly improved myo-inositol producing capability, suitable for use in recombinant DNA techniques and synthetic biology methods, to a host microorganism that does not possess an endogenous myo-inositol biosynthesis pathway, such as | 10-02-2014 |
| 20150322053 | PROCESSES FOR PREPARING OF GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATIVES AND INTERMEDIATES THEREIN - The present invention relates to processes for preparing the compounds of general formula I, | 11-12-2015 |
| 20160153016 | COMPOSITIONS AND METHODS FOR THE BIOSYNTHESIS OF VANILLIN OR VANILLIN BETA-D-GLUCOSIDE | 06-02-2016 |
| 20160200756 | Alkenyl Glycosides and Their Preparation | 07-14-2016 |
